COc1cccc2c1cc1c(=O)n(CC(=O)N3CCN(c4cccc(C)c4)C(C)C3)nc(C)n12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?